Glaxosmithkline Plc (GSK.L) has ended the quarter in the red, yielding negative results for the shares at they ticked -0.37% over that time frame. In taking a look at recent performance, we can see that shares have moved 3.76% over the past 4-weeks, -3.25% over the past half year and 16.31% over the past full year. Glaxosmithkline Plc ‘s weekly performance is at 0.41.
The direction of stock market moves in the short-term are highly unpredictable. Many investors will be tempted to ride the wave whether the trend is buying or selling. Fearful investors may make hasty decisions such as panic buying or selling. Investors may feel compelled to buy stocks after a major run higher. This can be related to the fear or missing out. On the other end, investors may be quick to sell quality stocks when the market is in the midst of a broad sell-off. This behavior often translates into falling into the trap of buying high and selling low.
Glaxosmithkline Plc (GSK.L) currently has a 14-day Commodity Channel Index (CCI) of 113.80. Active investors may choose to use this technical indicator as a stock evaluation tool. Used as a coincident indicator, the CCI reading above +100 would reflect strong price action which may signal an uptrend. On the flip side, a reading below -100 may signal a downtrend reflecting weak price action. Using the CCI as a leading indicator, technical analysts may use a +100 reading as an overbought signal and a -100 reading as an oversold indicator, suggesting a trend reversal.
When focusing on technical stock analysis, traders and investors may choose to study the ATR or Average True Range. The present 14-day ATR for Glaxosmithkline Plc (GSK.L) is currently standing at 36.78. The ATR basically measures the volatility of a stock on a day-to-day basis. The average true range is typically based on 14 periods and may be calculated daily, weekly, monthly, or intraday. The ATR is not considered a directional indicator, but it may reflect the strength of a particular move.
Currently, the 14-day ADX for Glaxosmithkline Plc (GSK.L) is sitting at 20.42. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend. A value of 25-50 would support a strong trend. A value of 50-75 would identify a very strong trend, and a value of 75-100 would lead to an extremely strong trend. ADX is used to gauge trend strength but not trend direction. Traders often add the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) to identify the direction of a trend.
Checking in on some other technical levels, the 14-day RSI is currently at 53.50, the 7-day stands at 57.44, and the 3-day is sitting at 48.39. Many investors look to the Relative Strength Index (RSI) reading of a particular stock to help identify overbought/oversold conditions. The RSI was developed by J. Welles Wilder in the late 1970’s. Wilder laid out the foundation for future technical analysts to further investigate the RSI and its relationship to underlying price movements. Since its inception, RSI has remained very popular with traders and investors. Other technical analysts have built upon the work of Wilder. The 14-day RSI is still a widely popular choice among technical stock analysts.
Investors may be watching other technical indicators such as the Williams Percent Range or Williams %R. The Williams %R is a momentum indicator that helps measure oversold and overbought levels. This indicator compares the closing price of a stock in relation to the highs and lows over a certain time period. A common look back period is 14 days. Glaxosmithkline Plc (GSK.L)’s Williams %R presently stands at -22.69. The Williams %R oscillates in a range from 0 to -100. A reading between 0 and -20 would indicate an overbought situation. A reading from -80 to -100 would indicate an oversold situation.
One of the biggest mistakes that can plague the individual investor is not setting up an overall investment plan. Investors may want to start out be setting up an outline of overall goals. Having goals can eventually make the day to day investing decisions at little bit easier over time. Once a plan is in place, investors can then spend more time focusing on the proper stocks to add to the portfolio. Dedicating time for extensive stock research may not be easy, but it may put the investor in a better position. Some investors will go to greater lengths, such as making sure that they have a good reason behind every buy or sell decision. This process may seem unnecessary to some, but it may help the investor stay focused when the market gets choppy and tough decisions need to be made.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.